Candace C. Fuller, MPH, PhD

Principal Research Scientist
Harvard Pilgrim Health Care Institute

Poster(s):

• (A-350) Baseline Characteristics of Patients Included in a Post-Approval Safety Study of Pfizer-BioNTech Monovalent COVID-19 Vaccine in the United States: Results From an Interim Analysis
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-333) Incidence Rates of Safety Events of Interest in a Post-Approval Study of Pfizer-BioNTech Original Monovalent COVID-19 Vaccine in the United States: Primary Series Analysis
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-334) Incidence rates of safety outcomes in a post-approval study of the Pfizer-BioNTech monovalent COVID-19 vaccine in the United States, booster dose analysis
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (A-221) Self-Reported Use of Non-FDA Approved Cannabinoid Products among Hospitalized Patients in a Large US Hospital Network
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET

• (C-063) Single-Dose Doxycycline for Lyme Disease Prophylaxis in Children in a Large United States Healthcare Database, 2016-2020
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET